Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
319 results about "Highly pathogenic" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
The highly pathogenic influenza A virus subtype H5N1 is an emerging avian influenza virus that is causing global concern as a potential pandemic threat. It is often referred to simply as "bird flu" or "avian influenza", even though it is only one of many subtypes.
Low virulent strain of porcine reproductive and respiratory syndrome virus, immunogenicity immunogenicity material and vaccine
The application relates to a domesticated porcine reproductive and respiratory syndrome virus low virulent strain (JXA1-R strain), immunogenicity substance containing the viral strain, and a porcine reproductive and respiratory syndrome virus low virulent live vaccine developed through making use of the strain. The live vaccine is used to prevent the porcine reproductive and respiratory syndrome, in particular the highly pathogenic blue-ear porcine disease.
Owner:CHINA ANIMAL DISEASE CONTROL CENT
Primer, probe series and method for multiple real time fluorescent RT-PCR detection of H5, H7 and H9 subtype bird flu
InactiveCN1670221AGood fast sensitivityStrong specificityMicrobiological testing/measurementFowlHighly pathogenic
Owner:TAITAI GENOMICS +1
Virus velogen strain for porcine reproductive and respiratory syndrome, attenuated vaccine strain thereof and application thereof
ActiveCN101280292AImprove securityNo side effectsViral antigen ingredientsMicrobiological testing/measurementDiseaseMicroorganism
The invention discloses a virulent strain HuN4 for porcine reproductive and respiratory syndrome, and an attenuated vaccine strain HuN4-F112 (the collection number of microorganism: CGMCC No.2484) attenuated because of virulent strain HuN4 passage, and also discloses the application of the attenuated vaccine strain in preventing or curing the highly pathogenic blue-ear disease, which belongs to the biomedical field. The attenuated vaccine strain HuN4-F112 can be prepared into single-vaccine or combined strain (live vaccine or inactivated vaccine), can effectively prevent or cure the highly pathogenic blue-ear disease, and also can be prepared into diagnostic reagent for the highly pathogenic blue-ear disease diagnosis. The attenuated vaccine strain HuN4-F112 of the invention has the advantages of good security and high protection efficiency.
Owner:HARBIN VETERINARY RES INST CHINESE ACADEMY OF AGRI SCI
Porcine reproductive and respiratory syndrome virus (PRRSV) double-antibody sandwich ELISA kit
The invention provides a porcine reproductive and respiratory syndrome virus double-antibody sandwich ELISA kit. The kit comprises: an elisa plate coated with PRRSV N protein monoclonal antibody, an enzyme labeling PRRSV N protein monoclonal antibody, lysis solution and the like. A capture antibody and a detection antibody are respectively aimed at antigenic determinants with different N proteins.The kit provides a reliable means for quick detection of clinical PRRSV antigen. The kit can detects that blood serum only contains 0.2 TCID50 highly pathogenic PRRSV JXwn06 strain (non-highly pathogenic strain can be also be detected). Through detecting clinically collected 80 blood serum samples, compared with RT-PCR result, the specificity of the method is 88 percent, the sensitiveness is 90 percent and the coincidence rate of the specificity and the sensitiveness are 88.8 percent. The kit is convenient for operation, low in use cost, good repetitiveness and suitable for wide promotion andapplication.
Owner:CHINA AGRI UNIV
Method for editing large white pig CD163 gene by using CRISPR/Cas9
InactiveCN108753832AEffective knockoutStable introduction of DNAPeptidesBiotechnologyHighly pathogenic
The invention discloses a method for editing a large white pig CD163 gene by using CRISPR / Cas9. The large white pig CD163 gene is edited by using the CRISPR / Cas9, the extracellular domain SRCR5 of a CD163 receptor is destroyed, the 7th exon DNA fragment of the CD163 gene is knocked out, and the nucleotide sequence of the 7th exon of the CD163 gene is represented by SEQ ID NO.1. The edited gene obtained by adopting the method can completely resist infection of PRRSV including a highly pathogenic strain HP-PRRSV, allows the cell surface CD163 receptor expression to be normal, and has normal other biological functions.
Owner:SUN YAT SEN UNIV
Gene encoding hemagglutinin protein of H5 avian influenza virus and its application
ActiveCN1632124AHigh level of immune responseImproving immunogenicityViral antigen ingredientsAntibody ingredientsHemagglutininHighly pathogenic
The present invention relates to an artificially synthesized gene optiHA containing codons for chicken partial tropism. Its reading frame contains 1707 bp nucleotides and encodes a total of 568 amino acids. The gene is compatible with H5 subtype highly pathogenic avian influenza virus A / Goose / GuangDong / 1 / 96(H5N1)[GD / 1 / 96(H5N1)]hemagglutinin (HA) gene has a nucleotide homology rate of 70%, an amino acid homology rate of 100%, and encodes the H5 subtype Hemagglutinin (HA) protein of avian influenza virus GD / 1 / 96 (H5N1). The invention also relates to the application of the gene as an immunogenic gene of H5 subtype influenza DNA vaccine and other genetic engineering vaccines.
Owner:HARBIN VETERINARY RES INST CHINESE ACADEMY OF AGRI SCI
Monoclonal antibodies specific to the fusion peptide from hemagglutinin from influenza A viruses and uses thereof
ActiveUS8540995B2Effective protectionMicrobiological testing/measurementBiological material analysisHemagglutininHighly pathogenic
Owner:TEMASEK LIFE SCIENCES LABORATORY
Honeysuckle composition for resisting virus diseases of pigs
The invention discloses a honeysuckle composition for resisting virus diseases of pigs, and relates to a feed additive or Chinese veterinary medicine special for preventing and controlling the virus diseases of the pigs and capable of promoting the growth of the pigs. The composition consists of the following components: 30 to 60 portions of honeysuckle extract, 5 to 20 portions of Chinese thorowax root extract, 5 to 20 portions of baical skullcap root P.E, 5 to 20 portions of dandelion P.E, and 10 to 25 portions of licorice extract. The composition is Chinese medicinal powder of which the granularity is between 200 and 300 meshes and which is yellow or brown-yellow, and has the following content of the active components: 5 to 20 percent of chlorogenic acid, 2 to 10 percent of baicalin and5 to 15 percent of glycyrrhizic acid. When used, the composition is mixed with a feed in a ratio of 0.02-0.2 percent and then is fed to animals. The composition has the effect of preventing and controlling highly pathogenic blue ear pig disease, porcine rotavirus disease, influenza, infectious bronchitis and the like, and virus diseases caused by porcine circovirus PCV, foot-and-mouth disease virus and the like, and can effectively promote the growth of the live pigs.
Owner:新乡博凯生物技术有限公司
Variant porcine reproductive and respiratory syndrome virus (PRRSV) TaqMan fluorescence quantitative RT-PCR detecting kit and application thereof
InactiveCN101736094AGuaranteed specificityStrong specificityMicrobiological testing/measurementMicroorganism based processesHighly pathogenicFluorescence
The invention discloses variant porcine reproductive and respiratory syndrome virus (PRRSV) TaqMan fluorescence quantitative RT-PCR detecting kit and application thereof. A primer and a TaqMan probe are designed and synthesized by referring to an NSP2 fragment gene sequence of the variant PRRSV and common PRRSV of a GenBank. By optimizing the reaction condition and constructing a standard plasmid product, a method for diagnosing the variant PRRSV by TaqMan fluorescence quantitative RT-PCR is established. A result indicates that the method has the advantages of strong specificity, high sensitivity, and the like and can detect the standard plasmid product with 264 copy numbers, and the virus quantity of 0.5623TICD50 is 10 times more sensitive than RT-PCR. By detecting 22 disease samples, 8 disease samples are positive, and the positive rate is 36.4 percent. Because the method has the advantages of quantification, high speed, accuracy, sensitivity, and the like, the invention is suitable for the diagnosis on the swinery infected variant PRRSV in the early stage, the medium stage and the later stage and plays an important role in effectively diagnosing, preventing and treating the highly pathogenic PRRSV.
Owner:INST OF ANIMAL HUSBANDRY & VETERINARY FUJIAN ACADEMY OF AGRI SCI +6
Specific binding PRRS (Porcine Reproductive and Respiratory Syndrome) virus non-structural protein Nsp9 nanobody and application thereof
ActiveCN104710528APrevent proliferationImmunoglobulins against virusesAntiviralsHighly pathogenicA-DNA
The invention relates to a specific PRRS (Porcine Reproductive and Respiratory Syndrome) virus non-structural protein Nsp9 nanobody and discloses a VHH (Variable Domain of Heavy-chain Antibody) sequence of the nanobody and a DNA sequence encoding the nanobody at the same time. The invention further provides an expression vector which can express nanobody-eGFP fusion protein in an Marc145 cell. The Nsp9 nanobody can be specifically bound with PRRS virus non-structural protein Nsp9, and has functions of inhibiting multiplication of a classic strain and a highly pathogenic strain of a PRRS virus in the Marc-145 cell. The nanobody can be developed into a drug for treating a PRRS, and a gene corresponding to the nanobody can be used for development of a PRRS resistance transgenic pig.
Owner:NORTHWEST A & F UNIV
Heat resisting protective agent of bivalent live vaccine against highly pathogenic porcine reproductive and respiratory syndrome-pseudorabies and preparation method thereof
InactiveCN102727904AAvoid damageReduce loss rateViral antigen ingredientsAntiviralsSucroseHighly pathogenic
The invention discloses a heat resisting protective agent of a bivalent live vaccine against highly pathogenic porcine reproductive and respiratory syndrome-pseudorabies, and a preparation method thereof. The heat resisting protective agent of the bivalent live vaccine against highly pathogenic porcine reproductive and respiratory syndrome-pseudorabies is prepared by the following materials by weight: 0.8 to 1.2% of gelatin, 4 to 6% of soybean peptone, 0.5 to 1.5% of glycine, 3 to 5% of sucrose, 2 to 3% of trehalose, 1 to 2% of polyvinyl pyrrolidone, 0.5 to 1% of mannitol, 0.1 to 0.2% of vitamin E and the rest being injection water. The preparation method comprises steps of high-temperature sterilization, filtration sterilization through a microporous membrane and mixing. The heat resisting protective agent of the bivalent live vaccine against highly pathogenic porcine reproductive and respiratory syndrome-pseudorabies of the invention reduces damage on virus activity caused by various physical and chemical factors during the freeze drying process, provides good protection and effectively solves the problems that a conventional protective agent of live vaccine needs refrigerated transport and storage is inconvenient.
Owner:GUANGDONG DAHUANONG ANIMAL HEALTH PRODS +1
Medicament for treating highly pathogenic blue ear disease and preparation method thereof
InactiveCN101411763AReasonable formulaUnique formulaSenses disorderAntiviralsDiseaseHighly pathogenic
The invention discloses a medicament for treating highly pathogenic porcine respiratory and reproductive syndrome and a method for preparing the same. The medicament is mainly prepared from rhubarb, dyers woad leaf, dandelion, southernwood, forsythia, gardenia, groundsel, plaster stone, scutellaria and astragalus. The preparation method comprises the following steps: according to a ratio, all materials are weighed up, the rhubarb is ground into powder, and soaked in boiling water for 30 minutes to form a leach solution, the 9 materials of dyers woad leaf, dandelion, southernwood, forsythia, gardenia, groundsel, plaster stone, scutellaria and astragalus are mixed for decoction and pentad temperature, the obtained liquid is mixed with the leach solution obtained after the rhubarb powder is soaked to prepare the medicament. The invention has the advantages of reasonable and unique formula, simple preparation process, low cost, little toxic and side effect and good control efficiency.
Owner:邵阳市家畜疫病防检站
Flu/human avian influenza virus detection gene chip and production method and use
InactiveCN101392302AShort detection timeImprove detection accuracyMicrobiological testing/measurementHighly pathogenicTyping
The invention discloses an influenza / human and avian influenza virus detection gene chip and a preparation method and an application thereof, 102 probes used for detecting A type, B type, H1N1 hipotype, H3N2 hipotype, H5N1 hipotype and H9N2 hipotype influenza viruses and 4 highly pathogenic differential diagnosis probes, as well as a process of sample treatment, hybridization, elution and chip identification which can carry out detection, typing or identification over the 6 types of viruses simultaneously and can identify the high pathogenicity of viruses. The invention not only greatly shortens the detection time of influenza viruses, but also improves the detection accuracy and provides a feasible technique support for the early warning mechanism of influenza epidemic situation in fields of clinical diagnosis, inspection quarantine, and the like.
Owner:中国疾病预防控制中心病毒病预防控制所 +1
Method for inhibiting influenza virus infection and medicament thereof
InactiveCN101186637APeptide/protein ingredientsGenetic material ingredientsHighly pathogenicHuman influenza
The invention relates to a method for restraining enveloped virus infection, relative polypeptide and protein drug, belonging to biological medicine technical field. The invention comprises a method for restraining influenza virus, particularly for restraining highly pathogenic influenza virus and human influenza virus (as H1N1 hypotype and H3N2 hypotype), relative polypeptide and protein, relative nucleic acid encoding the polypeptide and protein, and relative carriers and cells for representing the polypeptide and protein.
Owner:INST OF MICROBIOLOGY - CHINESE ACAD OF SCI
RT-RPA (reverse transcription recombinase polymerase amplification) detection kit for fast detecting high-pathogenicity porcine reproductive and respiratory syndrome virus and application thereof
ActiveCN105567871AShorten test timeLow reaction temperatureMicrobiological testing/measurementMicroorganism based processesBiologyDifferential diagnosis
The invention discloses an RT-RPA (reverse transcription recombinase polymerase amplification) detection kit for fast detecting a high-pathogenicity porcine reproductive and respiratory syndrome virus and application thereof. The kit comprises a pair of primers and a probe, the sequences of the primers are shown as SEQ ID NO.1 and SEQ ID NO.2, and the sequence of the probe is shown as SEQ ID NO.3. It is proved through experiments that the kit can detect adverse effects of the high-pathogenicity porcine reproductive and respiratory syndrome virus (HP-PRRSV), a hog cholera virus, a C-type porcine reproductive and respiratory syndrome virus, a porcine circovirus type II, a porcine pseudorabies virus and a foot and mouth disease virus in a specificity mode. It is proved through experiments that the kit can detect out templates of at least 70 copies at the temperature of 40 DEG C on the condition of 20 min amplification, and the conformity between the kit and RT-qPCR is high. This shows that the kit can detect HP-PRRSV fast, efficiently and sensitively and provides an effective technological means for differential diagnosis of HP-PRRSV.
Owner:LANZHOU INST OF VETERINARY SCI CHINESE ACAD OF AGRI SCI
Chicken infectivity bursa of Fabricius virus VP2 cDNA, its expression vector, expressed recombinant protein and application thereof
InactiveCN1990869APrevent proliferationBiologically activeFungiViral antigen ingredientsDiseaseHighly pathogenic
The invention discloses a novel chicken infectious bursal disease virusVP 2c DNA (SEQ ID NO: 1), construction of its expression carrier, expressed recombined VP2 protein and the application of said recombined protein in preparing subunit genetic engineering vaccine against chicken infection bursal disease virus. The chicken infectious bursal disease virusVP 2c DNA can be highly expressed in yeast cell, and expressed recombined protein possesses biological activity and immunogenicity of the chicken infectious bursal disease virus natural protein . The expressed recombined protein can be produced into vaccine, and it is demonstrated through immunity chicken test that: the protein subunit vaccine can effectively induce body to generate spcial humoral immune response, make immunity chicken get 90% protection from deadly attack of highly pathogenic vv IBDV, and effectively prevent virus proliferation in the body.
Owner:HARBIN VETERINARY RES INST CHINESE ACADEMY OF AGRI SCI
Dual real-time fluorescent RT-PCR identification and detection method of PRRSV classic strain and highly pathogenic mutant strain
ActiveCN101643794AGood fast sensitivityStrong specificityMicrobiological testing/measurementMicroorganism based processesHighly pathogenicPcr method
The invention discloses a dual real-time fluorescent RT-PCR method for identifying and detecting a PRRSV classic strain and a highly pathogenic mutant strain, and an RT-PCR cation primer and a probe against the PRRSV classic strain and the highly pathogenic mutant strain for the method. Compared with the prior art, the method is characterized by rapidness, simplicity, strong specificity, high sensitivity and good reliability and can simultaneously carry out large batch sample analysis, and one-time reaction can identify and diagnose whether a sample is infected by the PRRSV classic strain or infected by the PRRSV highly pathogenic mutant strain or infected by the two strains, thereby providing a powerful technical support for monitoring and controlling a PRRS epidemic disease and having good application prospects.
Owner:CHINA ANIMAL DISEASE CONTROL CENT
Nucleic acid detection kit for synchronously identifying and diagnosing newcastle disease virus and avian influenza virus
InactiveCN101240352AAvoid potential risksEasy to operateMicrobiological testing/measurementHighly pathogenicFluorescence
The invention belongs to the field of inspection and quarantine technology. Specifically, the invention is a nucleic acid detection reagent kit for synchronous discriminating and diagnosing avian influenza virus and newcastle disease virus. The detection reagents of the reagent kit include extraction reagent for extracting virus by silicon gel absorption column method, detection amplification reagent for detecting nucleic acid by RT-PCR Taq Man fluorescent probe method, and pretreatment liquid for solid tissue specimen for extracting virus RNA. Further, the invention employs in vitro transcription RNA as a positive contrast of the reagent kit. The reagent kit can rapidly and synchronously discriminate and diagnose avian influenza virus and newcastle disease virus which are highly infectious among avian plagues and have similar symptom, determine current major prevalent subtypes, such as H5, H7, H9, etc., and discriminate whether a infection source is an avian influenza having high pathogenicity, non-pathogenic avian influenza or mildly pathogenic avian influenza to human. The reagent kit is suitable for livestock and veterinarian station, import and export inspection and quarantine bureau, as well as other laboratories, and can be used for large-scale detection of influenza and epidemic surveillance.
Owner:SHANGHAI KEHUA BIO ENG
Nucleic acid composition, detection kit for influenza virus and micro-fluidic chip
PendingCN110283940ABioreactor/fermenter combinationsBiological substance pretreatmentsHighly pathogenicInfluenza a
The invention relates to nucleic acid composition, a detection kit for an influenza virus and a micro-fluidic chip. The nucleic acid composition comprises detection primer pairs, wherein the detection primer pairs comprise at least two of the following primer pairs: an influenza A primer pair, an influenza B primer pair, an influenza C primer pair, an influenza A H1 primer pair, an influenza A H3 primer pair, an influenza A H5 primer pair, an influenza A H7 primer pair, an influenza A H9 primer pair, an influenza A N9 primer pair and a high-pathogenicity influenza A H7N9 primer pair. According to the nucleic acid composition, interference between the primers and probes can be avoided, at least two influenza viruses are detected simultaneously once, and detection sensitivity can reach 100 copies / mL.
Owner:深圳市呈晖医疗科技有限公司
Gene engineering antibody of human source neutrality for anti virus H5N1 of bird flu
This invention provides a human-derived genetic engineering antibody that can specifically bond avian influenza virus H5N1. The genetic engineering antibody is derived from antibody gene library of avian influenza virus H5N1 patients in convalescence. The recombinant antibody is decided by hypervariable region (CDRs) specific gene sequence in the antibody light chain and heavy chain gene variable region, and is effectively expressed in procaryotic cells and eukaryotic cells. The recombinant antibody is a functional neutralizing antibody can specifically bond avian influenza virus haemagglutinin protein HA. Part or all genes of the antibody in CDR can modify and produce genetic engineering antibodies with different forms in procaryotic cells, yeast, insects and eukaryotic cells, and can prevent and treat diseases related to avian influenza virus H5N1.
Owner:中国疾病预防控制中心病毒病预防控制所
Cell inactivated vaccine, egg yolk antibody injection, and preparation method of cell inactivated vaccine
InactiveCN102716476AReduce lossesIncrease stimulationEgg immunoglobulinsViral antigen ingredientsDiseaseEpitope
The invention relates to a cell inactivated vaccine, an egg yolk antibody injection and a preparation method of the cell inactivated vaccine. The cell inactivated vaccine comprises a porcine circovirus antigenic epitope and a goose circovirus antigenic epitope. The preparation method of the cell inactivated vaccine comprises the following steps: firstly screening high-pathogenicity strains from the porcine circovirus, then selecting a plurality of virus epitopes having antibody immunocompetence from the strains, inserting the point of the porcine circovirus antigenic epitope into a goose circovirus genome by technologies such as purification and clone, and then carrying out viral multiplication in a large scale to obtain the cell inactivated vaccine. The invention also discloses the egg yolk antibody injection taking the cell inactivated vaccine as an antibody at the same time, the injection can be used for treating porcine circovirus diseases, takes effect quickly and has remarkable effects, meanwhile, a small dose can also be used for preventing the occurrence of the porcine circovirus diseases, so that the incidence rate is reduced and the economic benefit is improved. Meanwhile, the egg yolk antibody can also be used for treating the goose circovirus diseases. The preparation has lower stimulation on a human body, the working efficiency is further improved, and the feeding cost is lowered.
Owner:河南后羿生物工程股份有限公司
Vaccine strains of infectious clones of porcine reproductive and respiratory syndrome virus (PRRSV) and application thereof
ActiveCN101984061AEasy to solveEasy to controlViral antigen ingredientsMicrobiological testing/measurementHighly pathogenicAttenuated vaccine
The invention discloses an artificially cloned attenuated vaccine strains. The vaccine strains are strains cloned from attenuated vaccine strains HuN4-F112 of highly pathogenic porcine reproductive and respiratory syndrome virus (PRRSV), and marked restriction enzyme sites are introduced in the structural protein gene sequences of the strains. The invention also discloses a recombinant vector which comprises a full-length gene cDNA sequence of the attenuated vaccine strains HuN4-F112 of the highly pathogenic PRRSV. The 5'-end of the full-length gene cDNA sequence is additionally provided witha transcription promoter and the full-length gene cDNA sequence is internally introduced with the marked restriction enzyme sites. The artificially cloned attenuated vaccine strains of the invention can not only provide completely safe immune protection for resistance of an immune pig to the highly pathogenic PRRSV, but also effectively distinguish an immune pig of the PRRSV from a naturally infectious pig of the PRRSV, thus being beneficial to preventing and controlling the highly pathogenic PRRSV.
Owner:SHANGHAI VETERINARY RES INST CHINESE ACAD OF AGRI SCI
Heatproof lyophilized protective agent for live vaccine JXA1-R strain for highly pathogenic porcine reproductive and respiratory syndrome and method for preparing the same
Owner:CHINA ANIMAL DISEASE CONTROL CENT +1
Traditional Chinese medicine compositions for treating highly pathogenic reproductive and respiratory syndrome (PRRS)
ActiveCN102228636AImprove immunityHigh cure rateBacteria material medical ingredientsAntiviralsSide effectHighly pathogenic
Belonging to the field of traditional Chinese veterinary medicine, the invention discloses two traditional Chinese medicine compositions for treating highly pathogenic reproductive and respiratory syndrome. Wherein, one composition is mainly composed of crushed scutellaria, crushed andrographis paniculata, crushed dandelion, crushed Radix Astragali, crushed reed rhizome, crushed Herba Lopatheri,crushed herba fibraureae recisae, crushed honeysuckle, crushed forsythia and crushed licorice, and can be prepared into powder or premix. The other composition mainly consists of scutellaria extract, andrographis paniculata extract, dandelion extract, Radix Astragali extract, reed rhizome extract, Herba Lopatheri extract, herba fibraureae recisae extract, honeysuckle extract, forsythia extract and licorice extract, and can be prepared into injection, powder, aqueous agent, particulate agent or premix. The compositions of the invention have scientifically and reasonably proportioned materials, and the effective components can present increased curative effect through synergy. Thus, symptoms caused by highly pathogenic reproductive and respiratory syndrome can be alleviated and treated in different links. Able to address both the symptoms and root causes, the traditional Chinese medicine compositions of the invention have high cure rate, obvious curative effect, abundant medicine source, simple process, low cost, no medicine residue, and little toxic and side effect.
Owner:BEIJING KEEPYOUNG TECH
Porcine reproductive and respiratory syndrome virus RT-LAMP detection kit and detection method thereof
ActiveCN101575650AEfficient and specific amplificationThe detection process is fastMaterial analysis by observing effect on chemical indicatorMicrobiological testing/measurementRNA extractionHighly pathogenic
The invention relates to a porcine reproductive and respiratory syndrome virus RT-LAMP detection kit and a detection method thereof. Primers required by PRSSV RT-LAMP reaction system are designed according to the sequence of porcine reproductive and respiratory syndrome virus (PRSSV) published by GenBank; PRSSV virus RNA is extracted with the virus RNA extraction reagent (LBBII-RNA) designed and prepared by the inventor, the PRSSV RT-LAMP reaction system established in the invention is utilized for detection, and color developing agent is added after the reaction to judge the result; the result shows that the PRSSV virus RNA obtains efficient specific amplification after the reaction is conducted for 45 minutes at the temperature of 63 DEG C; and then, quick detection of porcine reproductive and respiratory syndrome virus American classical strain and NSP2 variant strain (highly pathogenic porcine reproductive and respiratory syndrome virus strain) is conducted by SpuI enzyme cutting. Compared with the prior art, the invention has quick detection, high sensitivity, low reaction cost, convenient and fast operation, which is capable of differentiating American classical strain and NSP2 variant strain (highly pathogenic porcine reproductive and respiratory syndrome virus strain) and meets the requirement of multi-level detection.
Owner:CHINA INST OF VETERINARY DRUG CONTROL
Recombinant porcine reproductive and respiratory syndrome virus as well as preparation method and application thereof
The invention discloses a recombinant porcine reproductive and respiratory syndrome virus as well as a preparation method and an application thereof. The recombinant porcine reproductive and respiratory syndrome virus provided by the invention is the recombinant virus which is obtained by carrying out substitution or deletion on a wild recombinant porcine reproductive and respiratory syndrome viral genome RNA; the substitution means carrying out substitution on all or a part of six structural proteins including a structural protein ORF2a, a structural protein ORF2b, a structural protein ORF3, a structural protein ORF4, a structural protein ORF5a and a structural protein ORF5 in the wild recombinant porcine reproductive and respiratory syndrome viral genome RNA as coding RNAs of labelled proteins; and the deletion means carrying out deletion on all or a part of coding RNAs of the six structural proteins in the wild recombinant porcine reproductive and respiratory syndrome viral genome RNA. The experiments prove that the recombinant virus has a good prevention effect on a high pathogenicity porcine reproductive and respiratory syndrome and has great importance to a porcine reproductive and respiratory syndrome viral vaccine.
Owner:CHINA AGRI UNIV
Detection kit and application thereof
The invention provides a detection kit containing two anti-porcine circovirus 2 type monoclonal antibodies, two anti-classical swine fever virus monoclonal antibodies and / or two anti-highly pathogenic porcine reproductive and respiratory syndrome virus monoclonal antibodies; the kit can be applied for simultaneous detection of a porcine circovirus 2 type antigen, a classical swine fever virus antigen and / or a highly pathogenic porcine reproductive and respiratory syndrome virus antigen with non-diagnostic purpose, moreover, the detection sensitivity of the kit for simultaneous detection of two or three kinds of viruses is higher than that for the detection of single virus, and false positive results are avoided.
Owner:LUOYANG PULIKE WANTAI BIOTECH
Ursolic acid saponin, preparation method thereof and application in resisting highly pathogenic H5N1 influenza virus
InactiveCN101941996AFast preparationShort synthetic routeOrganic active ingredientsSugar derivativesAnti virusHighly pathogenic
The invention discloses ursolic acid saponin, a preparation method thereof and application in resisting highly pathogenic H5N1 influenza virus, and specifically relates to ursolic acid saponin compounds shown in general formula (I). A series of ursolic acid saponin is prepared from natural product ursolic acid serving as raw material by introducing an ester group into the C-28 site through structural modification at first, then introducing beta-glucosyl into the C-3 site, selectively protecting 3,6-OHs of the glucose by using BBTZ and introducing glycosyl into 2,4-OHs of the glucose. Pharmacological test shows that the ursolic acid saponin compounds have obvious inhibition effect on the invasion process of the H5N1 highly pathogenic influenza viruses on host cells and can be used as a medicament for preventing or treating the influenza viruses. The invention also discloses a pharmaceutical composition containing the ursolic acid saponin compounds and the combination of the compounds of the invention and other anti-virus medicines.
Owner:INST OF MATERIA MEDICA AN INST OF THE CHINESE ACAD OF MEDICAL SCI +1
Classical swine fever virus virulence determinant and a novel classical swine fever vaccine
InactiveUS7332170B1Readily apparentSsRNA viruses positive-senseViral antigen ingredientsHighly pathogenicVirulent characteristics
Transposon linker insertion mutagenesis of a full-length infectious clone of the highly pathogenic classical swine fever virus (CSFV) isolate Brescia (pBIC) was used to identify genetic determinants of CSFV virulence and host range. A virus mutant, RB-C22 (RB-C22v), possessing a 19-residue tag insertion at the carboxyl end of E1 was constructed. RB-C22v and the parental virus pBIC (pBICv) exhibited similar growth characteristics on primary porcine macrophage cell cultures although RB-C22v produced significantly smaller plaques on SK6 cell cultures. In vivo, RB-C22v was markedly attenuated in swine. In contrast with pBIC infection, where mortality was 100%, all RB-C22v-infected pigs survived infection remaining clinically normal. Additionally, chimeras of the Brescia strain and the attenuated vaccine strain CS were constructed and evaluated for viral virulence in swine. Chimeras 138.8v and 337.14v, chimeras containing the E2 glycoprotein of CS and chimeric virus 319.1v, which contained only the CS E2 glycoprotein in the Brescia background, were attenuated in swine. Chimeras encoding all Brescia structural proteins in a CS genetic background remained attenuated, indicating that additional mutations outside the structural region are important for CS vaccine virus attenuation. The combined results indicate a significant role for E1 glycoprotein and E2 glycoprotein in swine virulence.
Owner:UNITED STATES OF AMERICA AS RESPRESENTED BY THE SEC OF AGRI THE
Reverse transcription-polymerase chain reaction (RT-PCR) detection for porcine reproductive and respiratory syndrome virus and classical swine fever virus and special primers for same
InactiveCN102586477AStrong specificityLow homologyMicrobiological testing/measurementDNA/RNA fragmentationHighly pathogenicNucleotide sequencing
The invention discloses reverse transcription-polymerase chain reaction (RT-PCR) detection for porcine reproductive and respiratory syndrome virus and classical swine fever virus and special primers for same. The invention provides the special primers for detecting the viruses. The special primers comprise a primer pair A and a primer pair B, wherein the primer pair A comprises a primer 1 and a primer 2; the primer pair B comprises a primer 3 and a primer 4; and nucleotide sequences of the primers 1, 2, 3 and 4 are sequences 1, 2, 3 and 4 in a sequence table. Experiments prove that: by the multiplex RT-PCR detection method for the porcine reproductive and respiratory syndrome virus and the classical swine fever virus, a classical porcine reproductive and respiratory syndrome virus strain, a high pathetic porcine reproductive and respiratory syndrome virus strain and the classical swine fever virus can be simultaneously detected through once reaction, and the method has a good application prospect on clinical diagnosis.
Owner:山东省动物疫病预防与控制中心
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com